Perceptions and feelings of a French sample regarding lung cancer screening

Author:

Darnaud Nicolas,Mory Jean-Eudes,Romy Pascal,Berger Jacques,Eve Karine,Lantheaume Sophie

Abstract

Abstract Introduction This study investigated the perceptions and feelings of a French sample about the possible introduction of lung cancer screening. Methods A total of 146 individuals, aged between 19- and 64-years, participated in this study conducted between November 2020 and January 2021. Participants were divided into three groups according to their smoking status: (i) active smokers (G1); former smokers (G2); and non-smokers (G3). Each individual completed an online questionnaire evaluating their perceptions and feelings about lung cancer, screening and scans. Results Overall, a higher percentage of former smokers (47%) indicated a greater willingness to participate in lung cancer screening compared to active smokers (19%) and non-smokers (32%). Active smokers and former smokers reported anxiety about the development of lung cancer. Active smokers who wished to participate in screening reported a greater motivation to reduce their tobacco consumption. The perception of lung cancer risk had less influence than age and socio-economic category on the participation in screening. Finally, stigma did not appear to be a barrier to undergoing screening. Conclusion Active and former smokers were generally optimistic about screening; however, active smokers showed less inclination to participate in screening compared to former smokers and non-smokers. Three main factors appeared to influence this participation: the perception of the risk of developing cancer, age and socio-economic category.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Reference34 articles.

1. Institut National du cancer (INCa). Le cancer du poumon - Les cancers les plus fréquents [en ligne]. 2022. https://www.e-cancer.fr/Professionnels-de-sante/Les-chiffres-du-cancer-en-France/Epidemiologie-des-cancers/Les-cancers-les-plus-frequents/Cancer-du-poumon. Accessed 6 Sept 2022.

2. Rosell R, González-Cao M. Ablating lung cancer, knowing the tumor better. The Lancet Regional Health – Europe. 2022;22:100494.

3. Bichsel N. La stigmatisation: un problème fréquent aux conséquences multiples. Rev Méd Suisse. 2017;13:478–81. https://www.revmed.ch/view/436968/3748571/RMS_551_478.pdf. Accessed 6 Sept 2022.

4. Dubin RE, Kaplan A, Graves L, Ng VK. Reconnaître la stigmatisation. Sa présence dans les soins aux patients et dans la formation médicale. Can Fam Physician. 2017;63(12):913–5.

5. Chambers SK, Dunn J, Occhipinti S, et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer. 2012;12:184. https://doi.org/10.1186/1471-2407-12-184.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3